Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/181023
The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Plaques of the amyloid beta (Aβ) peptide are a pathological hallmark of Alzheimer's Disease (AD), the most common form of dementia. Mutations in Aβ also cause familial forms of AD (fAD). Here we use deep mutational scanning to quantify the effects of >14,000 mutations on the aggregation of Aβ. The resulting genetic landscape reveals mechanistic insights into fibril nucleation, including the importance of charge and gatekeeper residues in the disordered region outside of the amyloid core in preventing nucleation. Strikingly, unlike computational predictors and previous measurements, the empirical nucleation scores accurately identify all known dominant fAD mutations in AB42, genetically validating that the mechanism of nucleation in a cell-based assay is likely to be very similar to the mechanism that causes the human disease. These results provide the first comprehensive atlas of how mutations alter the formation of any amyloid fibril and a resource for the interpretation of genetic variation in Aβ.© 2021, Seuma et al.
Matèries
Matèries (anglès)
Citació
Citació
SEUMA, Mireia, FAURE, André j., BADIA, Marta, LEHNER, Ben, BOLOGNESI, Benedetta. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations. _Elife_. 2021. Vol. 10. [consulta: 5 de maig de 2026]. ISSN: 2050-084X. [Disponible a: https://hdl.handle.net/2445/181023]